Aws Alshamsan
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 28
- Advancements in Transdermal Drug Delivery 7
-
- RNA Interference and Gene Delivery 16
- Co-authors
- Mohd Abul Kalam (38 shared papers)Maqusood Ahamed (13 shared papers)Hisham A. Alhadlaq (12 shared papers)Mohd Javed Akhtar (11 shared papers)John Samuel (8 shared papers)Afsaneh Lavasanifar (13 shared papers)M.A. Majeed Khan (6 shared papers)Musaed Alkholief (31 shared papers)
- Journals
- Saudi Pharmaceutical Journal (20 papers)Pharmaceutics (6 papers)Molecules (4 papers)International Journal of Pharmaceutics (4 papers)Scientific Reports (4 papers)
- Partner nations
- Saudi ArabiaCanadaIndia
In The Last Decade
Aws Alshamsan
106 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 162
- Pharmaceutical Science 778
- Biomaterials 724
- Molecular Medicine 121
- Immunology 446
- Materials Chemistry 847
Countries citing papers authored by Aws Alshamsan
This map shows the geographic impact of Aws Alshamsan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aws Alshamsan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aws Alshamsan more than expected).
Fields of papers citing papers by Aws Alshamsan
This network shows the impact of papers produced by Aws Alshamsan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aws Alshamsan. The network helps show where Aws Alshamsan may publish in the future.
Co-authors
The 25 scholars most cited alongside Aws Alshamsan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 203 | |
| 2 | 2017 | 155 | |
| 3 | 2017 | 140 | |
| 4 | 2008 | 136 | |
| 5 | 2015 | 132 | |
| 6 | 2019 | 108 | |
| 7 | 2009 | 97 | |
| 8 | 2017 | 96 | |
| 9 | 2006 | 93 | |
| 10 | 2010 | 89 | |
| 11 | 2016 | 88 | |
| 12 | 2013 | 86 | |
| 13 | 2017 | 79 | |
| 14 | 2016 | 79 | |
| 15 | 2016 | 75 | |
| 16 | 2016 | 74 | |
| 17 | 2021 | 74 | |
| 18 | 2007 | 73 | |
| 19 | 2014 | 68 | |
| 20 | 2016 | 61 |
About Aws Alshamsan
Aws Alshamsan is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Materials Chemistry and Public Health, Environmental and Occupational Health, having authored 109 papers that have together received 3.7k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (28 papers), RNA Interference and Gene Delivery (16 papers), Nanoparticle-Based Drug Delivery (16 papers), Nanoparticles: synthesis and applications (13 papers), Ocular Surface and Contact Lens (12 papers), Immunotherapy and Immune Responses (9 papers), Pharmacological Effects of Natural Compounds (8 papers) and Advancements in Transdermal Drug Delivery (7 papers). The work is most often cited by research in Pharmaceutical Science (778 citations), Biomaterials (724 citations), Molecular Medicine (121 citations), Immunology (446 citations) and Materials Chemistry (847 citations). Aws Alshamsan has collaborated with scholars based in Saudi Arabia, Canada and India. Frequent co-authors include Mohd Abul Kalam, Maqusood Ahamed, Hisham A. Alhadlaq, Mohd Javed Akhtar, John Samuel, Afsaneh Lavasanifar, M.A. Majeed Khan, Musaed Alkholief, Samar Hamdy and Abdulaziz Almalik. Their work appears in journals such as Saudi Pharmaceutical Journal, Pharmaceutics, Molecules, International Journal of Pharmaceutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.